ArticleExperimental and therapeutic medicine2021

Combination treatment with cisplatin, paclitaxel and olaparib has synergistic and dose reduction potential in ovarian cancer cells.

Jianwen Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.